(Q42210562)

18 October 2017

title

Qualitative and quantitative drug-susceptibility tests in mycobacteriology (English)

1 reference

18 October 2017

Heifets L

1

1 reference

18 October 2017

publication date

1 May 1988

1 reference

The American Review of Respiratory Disease

18 October 2017

published in

1 reference

18 October 2017

volume

137

1 reference

18 October 2017

issue

5

1 reference

18 October 2017

page(s)

1217-1222

1 reference

Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factors

18 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F137.5.1217

The inhibitory quotient. A method for interpreting minimum inhibitory concentration data

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F137.5.1217

Pulmonary mycobacterial infections due to Mycobacterium intracellulare-avium complex. Clinical features and course in 100 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F137.5.1217

Treatment of pulmonary infections caused by mycobacteria of the Mycobacterium avium-intracellulare complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F137.5.1217

Rifabutine: minimal inhibitory and bactericidal concentrations for Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F137.5.1217

In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F137.5.1217

In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F137.5.1217

Determination of in vitro susceptibility of Mycobacterium tuberculosis to cephalosporins by radiometric and conventional methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F137.5.1217

Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F137.5.1217

Ciprofloxacin concentrations in bone and muscle after oral dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F137.5.1217

10.1164/AJRCCM/137.5.1217

21 January 2018

Identifiers

DOI

1 reference

18 October 2017

1 reference